These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 1988509

  • 1. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, Friedland G.
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.
    Schwebke J, Calsyn D, Shriver K, Saxon A, Kleyn J, Oluoch-Mitchell E, Olmstead L, Fisher LD, Krone M, Ashley R.
    J Infect Dis; 1994 May; 169(5):962-7. PubMed ID: 8169427
    [Abstract] [Full Text] [Related]

  • 5. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S, Krook A, Käll K, Julander I, Thorstensson R, Biberfeld G.
    Scand J Infect Dis; 1995 May; 27(6):547-50. PubMed ID: 8685631
    [Abstract] [Full Text] [Related]

  • 6. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W, Sanabani SS, Jamal LF, Sabino EC.
    Rev Soc Bras Med Trop; 2009 May; 42(3):264-70. PubMed ID: 19684973
    [Abstract] [Full Text] [Related]

  • 7. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI, Gaudino JA, Hanson CV.
    J Psychoactive Drugs; 1991 May; 23(2):225-32. PubMed ID: 1765894
    [Abstract] [Full Text] [Related]

  • 8. HTLV infection among Italian intravenous drug users and North African subjects detected by the polymerase chain reaction and serological methods.
    Colombo E, Magistrelli C, Mendozzi E, Cattaneo E, Achilli G, Ferrante P.
    J Med Virol; 1995 Sep; 47(1):10-5. PubMed ID: 8551251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.
    Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP.
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):715-7. PubMed ID: 12853410
    [Abstract] [Full Text] [Related]

  • 12. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB, Lai SH, Chitwood DD, Klimas NG, Smith PC, Fletcher MA.
    Lancet; 1990 Jun 16; 335(8703):1439-41. PubMed ID: 1972217
    [Abstract] [Full Text] [Related]

  • 13. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F, Wattel E, Mariotti M, Agis F, Gordien E, Lefrère JJ.
    J Infect Dis; 1992 Jul 16; 166(1):212-3. PubMed ID: 1607702
    [No Abstract] [Full Text] [Related]

  • 14. Patterns of HIV-1 and HTLV-I/II in intravenous drug abusers from the middle atlantic and central regions of the USA.
    Lee HH, Weiss SH, Brown LS, Mildvan D, Shorty V, Saravolatz L, Chu A, Ginzburg HM, Markowitz N, Des Jarlais DC.
    J Infect Dis; 1990 Aug 16; 162(2):347-52. PubMed ID: 2373871
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.
    Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, Eklund I, Engström A, Julander I, Käll K, Martin C, Stendahl P, Struve J, Sönnerborg A.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Aug 15; 15(5):381-6. PubMed ID: 9342259
    [Abstract] [Full Text] [Related]

  • 16. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses.
    Pancake BA, Zucker-Franklin D, Marmor M, Legler PM.
    Proc Assoc Am Physicians; 1996 Nov 15; 108(6):444-8. PubMed ID: 8956367
    [Abstract] [Full Text] [Related]

  • 17. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA, Al EJ, Huisman JG, Goudsmit J, Coutinho RA.
    J Med Virol; 1991 Jun 15; 34(2):100-3. PubMed ID: 1890409
    [Abstract] [Full Text] [Related]

  • 18. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jiménez V, Silva T, Project Itínere Working Group.
    J Clin Virol; 2006 Mar 15; 35(3):244-9. PubMed ID: 16143565
    [Abstract] [Full Text] [Related]

  • 19. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook EW, Blattner WA, Quinn TC.
    J Infect Dis; 1992 May 15; 165(5):920-4. PubMed ID: 1569344
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.